COLL vs MTD · P/E 17, rev $181.9M vs P/E 27, rev $3.87B
Collegium Pharmaceutical Inc (COLL) versus Mettler-Toledo International Inc (MTD) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Mettler-Toledo International Inc (MTD) is a diagnostics & research company listed on NYSE.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported MTD revenue for 2024-12-31 was $3.87B. Net income was $863.1M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
Not investment advice. Open the COLL and MTD stock pages for the full models.
Not investment advice.